Sandeep Dube, MD
Interventional Cardiology · Indianapolis, INNPI 1952350597
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 89.0% of it on its own, with 15 other manufacturers making up the rest.
Across 129 payments — averaging $161.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$19K
- Boston Scientific$897
- Abbott$512
- Cardiac Dimensions, Inc.$214
- Biosense Webster, Inc.$128
- Asahi Intecc USA, Inc.$106
- plus $445 from 10 others
Across 86 payments — averaging $2119.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$179K
- Boston Scientific$3K
What the payments were for
- Consulting fees$7,40035%
- Speaking & faculty fees$1,5007%
- Travel & lodging$5,53226%
- Food & beverage$6,43831%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 81 | $18,580 |
| Boston Scientific | 20 | $897 |
| Abbott | 7 | $512 |
| Cardiac Dimensions, Inc. | 1 | $214 |
| Biosense Webster, Inc. | 1 | $128 |
| Asahi Intecc USA, Inc. | 1 | $106 |
| Livanova USA, Inc. | 2 | $105 |
| Abiomed | 1 | $100 |
| Medtronic(2 entities) | 6 | $88 |
| Angiodynamics, Inc. | 2 | $36 |
| Pfizer | 2 | $30 |
| Atricure, Inc. | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $21 |
| Altathera Pharmaceuticals LLC | 1 | $18 |
| Shockwave Medical, Inc | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,881 in reported general payments places this provider in the 80th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 28 | $137 |
| Rosuvastatin Calcium | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Indianapolis
- James HermillerIndianapolis$307K
- Woodrow CoreyIndianapolis$262K
- Michael BallIndianapolis$76K
- Anjan SinhaIndianapolis$54K
- Nitesh GadeelaIndianapolis$48K
- George RevtyakIndianapolis$45K
- Scott SharpIndianapolis$41K
- Amrish MalhiIndianapolis$37K
- Jeffrey BreallIndianapolis$21K
- Kevin BallIndianapolis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.